2024 Abstract Submission Guidelines

ABSTRACT INFORMATION
The abstract submission portal is now active. 

SAVE THE DATE! The abstract submission deadline is 11:59 PM EDT on October 12, 2023. 

Walsh Cases: WHAT'S NEW?

• Walsh submissions not accepted for presentation may be given the opportunity to resubmit as a Descriptive Studies poster if they are above the mean rating of the Walsh committee rating.
• Only one submission per first/presenting author is allowed per abstract category.
• View full Walsh Submission Guidelines here. 

Analytical and Descriptive Studies: WHAT'S NEW?

• In 2024 there will be no ePoster submissions, only printed posters.
• All printed posters should be no larger than 3.1’x3.1’! More information will be provided in acceptance notifications.
• View full Abstract Submission Guidelines here. 

NEW! Reasons Your Abstract Can Be Rejected

While NANOS strives to accept all abstracts that are of adequate scientific quality and in particular to support the presentation of abstracts by trainees, several reasons can result in your abstract being rejected. These include but are not limited to

• No data presented, only plans (except, e.g., when the purpose is to present the design of a complex study). The abstract committee strongly suggests that even trainees who may have had limited time in their programs before the abstract deadline to include some data in their results, e.g., the expected number of charts to be reviewed, interim results, etc. In some cases, the abstract committee may permit authors to resubmit more developed abstracts before the deadlines for producing the syllabus.
• No or unclear relationship to neuro-ophthalmology
• Poorly written English that makes the abstract unable to be understood
• Clear commercial bias (e.g., advertising)
• Failure to follow submission instructions, formatting, etc.

NANOS Trainee Award Criteria: WHAT'S NEW?

• The NANOS Abstract Committee aims to promote the work of supervised medical students, residents, and fellows-in-training who represent the future of neuro-ophthalmology. Due to the wide variety of structures for training programs, especially internationally, the positions of all trainees nominated for awards will be reviewed to ensure they are reasonably equivalent to the relevant award category and ensure a fair competition. This review will be undertaken by one or more members assigned by the NANOS board who are familiar with international training programs. The decisions regarding award eligibility of this group in coordination with the Abstract Committee will be considered final. Awards for the best work performed and presented by a supervised student (eligible students are current medical students - MD, DO - or students in a doctoral program - PhD or equivalent - who have not already completed a medical degree), resident, and fellow-in-training are available.
• To be eligible for consideration for these trainee awards, the presenting author must be in a training program leading to a degree or medical certification at the time of abstract submission and their nomination must be supported by their supervisor.  Individuals applying for trainee awards are responsible for ensuring that they meet the appropriate eligibility criteria and provide the necessary information with which to verify this during the abstract submission process.  This will be verified prior to award distribution. Due to the wide variety of structures for training programs, especially internationally, the positions of all trainees nominated for awards will be reviewed to ensure they are reasonably equivalent to the relevant award category and ensure a fair competition. This review will be undertaken by one or more members assigned by the NANOS board who are familiar with international training programs. The decisions regarding award eligibility of this group in coordination with the Abstract Committee will be considered final.

REMINDER! All platform/Walsh acceptances are subject to CME approval and no employees of ineligible companies* can present.

*  Ineligible companies: companies that are ineligible to be accredited in the ACCME System (now known as ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
• Compounding pharmacies that manufacture propriety compounds
• Device manufacturers or distributors
• Diagnostic labs that sell propriety products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

Award Winners for the Walsh & Abstracts will be announced at the Luau Dinner on Wednesday night (March 6th 2023). 

If you have a question about your submission please contact meetings@nanosweb.org 

FREQUENTLY ASKED QUESTIONS
WHAT IS THE FORMAT OF THE NANOS 2024 ANNUAL MEETING? 
The meeting will be held in-person in Sheraton Waikiki, HI, with on-demand viewing available after the live event. 

IS THERE A VIRTUAL COMPONENT TO THE MEETING?
On Demand content will be available for CME credit. Check in later for exact dates. 

WHAT IS THE CANCELLATION POLICY?
As the CME Content will be published for On Demand viewing, no refunds will be issued.

IS THE ROOM SHARE AVAILABLE AGAIN THIS YEAR?
Please click here to access a Google doc, which is designed to connect attendees with one another in order to share accommodations at Sheraton Waikiki, HI. Please provide your full name, contact information, and other relevant comments. Use this document to directly connect with other people on the list looking for a roommate.